Key TxCell patent to be granted in Japan for its lead product Ovasave®

News   Mar 10, 2016

 
Key TxCell patent to be granted in Japan for its lead product Ovasave®
 
 
 

RELATED ARTICLES

Evolution Threatens Efficient Bioproduction Scale-Up

News

The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.

READ MORE

Sequencing Shows How Evolution Can Undermine Bioprocess Commercialization

News

Rapid evolution can suppress the effect of pro-production genes in biochemical processes.

READ MORE

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE